KM Financial Solutions | Why Oppenheimer Global fund is focusing on biotech as rates rise
10868
post-template-default,single,single-post,postid-10868,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Why Oppenheimer Global fund is focusing on biotech as rates rise

Why Oppenheimer Global fund is focusing on biotech as rates rise

NEW YORK, Feb 27 (Reuters) – The recent volatility in the
global stock market may make some investors feel queasy, but it
is providing a buying opportunity in biotechnology stocks.

No Comments

Sorry, the comment form is closed at this time.